SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-060635
Filing Date
2024-07-11
Accepted
2024-07-11 08:31:06
Documents
16
Period of Report
2024-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209277-8k_onconetix.htm   iXBRL 8-K 41178
2 FORM OF INDUCEMENT PIO ea020927701ex4-1_onconetix.htm EX-4.1 113176
3 FORM OF INDUCEMENT LETTER ea020927701ex10-1_onconetix.htm EX-10.1 54455
4 PRESS RELEASE, DATED JULY 11, 2024 ea020927701ex99-1_onconetix.htm EX-99.1 11812
  Complete submission text file 0001213900-24-060635.txt   449370

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE onco-20240711.xsd EX-101.SCH 3042
6 XBRL LABEL FILE onco-20240711_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE onco-20240711_pre.xml EX-101.PRE 22377
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0209277-8k_onconetix_htm.xml XML 3681
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 241111087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)